These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 22819541)

  • 1. [Cost and cost-effectiveness analysis of the preferred treatment for initial antiretroviral therapy in HIV infected adults according to 2012 GESIDA/National AIDS Plan guidelines].
    Betegón L; Cotarelo M; Vendrell B
    Enferm Infecc Microbiol Clin; 2012 Oct; 30(8):508-9; author reply 511-2. PubMed ID: 22819541
    [No Abstract]   [Full Text] [Related]  

  • 2. [Analysis of costs and cost-effectiveness of the preferred treatments by GESIDA/National plan for AIDS for initial antiretroviral therapy in 2012].
    Martín-Herrero JE; Parrondo-García J; Rodríguez-Alcántara F
    Enferm Infecc Microbiol Clin; 2012 Oct; 30(8):509-10; author reply 511-2. PubMed ID: 22824178
    [No Abstract]   [Full Text] [Related]  

  • 3. [Costs and cost-efficacy analysis of the preferred treatments by GESIDA/National Plan for AIDS for the initial antiretroviral therapy in adult human immunodeficiency virus (HIV) infected patients in 2012].
    Blasco AJ; Arribas JR; Boix V; Clotet B; Domingo P; González-García J; Knobel H; López JC; Llibre JM; Lozano F; Miró JM; Podzamczer D; Santamaría JM; Tuset M; Zamora L; Lázaro P; Gatell JM;
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):283-93. PubMed ID: 22525829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs and cost-efficacy analysis of the 2016 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.
    Rivero A; Pérez-Molina JA; Blasco AJ; Arribas JR; Crespo M; Domingo P; Estrada V; Iribarren JA; Knobel H; Lázaro P; López-Aldeguer J; Lozano F; Moreno S; Palacios R; Pineda JA; Pulido F; Rubio R; de la Torre J; Tuset M; Gatell JM
    Enferm Infecc Microbiol Clin; 2017 Feb; 35(2):88-99. PubMed ID: 27459919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Costs and cost effectiveness analysis of preferred GESIDA regimens for initial antiretroviral therapy].
    Blasco AJ; Arribas JR; Clotet B; Domingo P; González-García J; López-Bernaldo JC; Llibre JM; Lozano F; Podzamczer D; Santamaría JM; Tuset M; Zamora L; Lázaro P; Gatell JM
    Enferm Infecc Microbiol Clin; 2011 Dec; 29(10):721-30. PubMed ID: 22014894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs and cost-effectiveness analysis of 2015 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.
    Berenguer J; Rivero A; Blasco AJ; Arribas JR; Boix V; Clotet B; Domingo P; González-García J; Knobel H; Lázaro P; López JC; Llibre JM; Lozano F; Miró JM; Podzamczer D; Tuset M; Gatell JM;
    Enferm Infecc Microbiol Clin; 2016; 34(6):361-71. PubMed ID: 26321131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs and cost-efficacy analysis of the 2014 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.
    Blasco AJ; Llibre JM; Berenguer J; González-García J; Knobel H; Lozano F; Podzamczer D; Pulido F; Rivero A; Tuset M; Lázaro P; Gatell JM;
    Enferm Infecc Microbiol Clin; 2015 Mar; 33(3):156-65. PubMed ID: 25175171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Budget impact analysis of antiretroviral therapy. A reflection based on the GESIDA guidelines].
    Grupo de trabajo de la Cohorte VACH
    Gac Sanit; 2012; 26(6):541-6. PubMed ID: 22498716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [HIV infection and AIDS from the health policy viewpoint. Savings and therapy superiority maintained - a contradiction in HIV therapy?].
    MMW Fortschr Med; 2014 Jun; 156 Suppl 1():62-3. PubMed ID: 25026863
    [No Abstract]   [Full Text] [Related]  

  • 10. [GESIDA/National AIDS Plan: Consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (Updated January 2015)].
    Panel de expertos de GeSIDA y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2015 Oct; 33(8):543.e1-43. PubMed ID: 25959461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost/efficacy analysis of preferred Spanish AIDS study group regimens and the dual therapy with lopinavir/ritonavir plus lamivudine for initial ART in HIV infected adults.
    Gatell Artigas JM; Arribas López JR; Lázaro Y de Mercado P; Blasco Bravo AJ
    Enferm Infecc Microbiol Clin; 2016; 34(7):427-30. PubMed ID: 25749416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The cost of an HIV patient. Lack of funds for optimal treatment?].
    Stoll M; Schulte E; Claes C; Graf von der Schulenburg JM; Schmidt RE
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():72-7. PubMed ID: 11373789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Declining costs].
    Neumaier J
    MMW Fortschr Med; 2016 Jun; 158 Suppl 1():58. PubMed ID: 27259908
    [No Abstract]   [Full Text] [Related]  

  • 15. Exploring the costs of a limited public sector antiretroviral treatment programme in South Africa.
    Boulle A; Kenyon C; Skordis J; Wood R
    S Afr Med J; 2002 Oct; 92(10):811-7. PubMed ID: 12432807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Not Available].
    Wolf E; Rüsenberg R
    MMW Fortschr Med; 2015 Jun; 157 Suppl 2():42-5. PubMed ID: 26048120
    [No Abstract]   [Full Text] [Related]  

  • 17. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
    Panel de expertos de GESIDA y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of costs and cost-effectiveness of preferred GESIDA/National AIDS Plan regimens for initial antiretroviral therapy in human immunodeficiency virus infected adult patients in 2013].
    Blasco AJ; Llibre JM; Arribas JR; Boix V; Clotet B; Domingo P; González-García J; Knobel H; López JC; Lozano F; Miró JM; Podzamczer D; Santamaría JM; Tuset M; Zamora L; Lázaro P; Gatell JM;
    Enferm Infecc Microbiol Clin; 2013 Nov; 31(9):568-78. PubMed ID: 23969276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV/AIDS. Triple jump.
    Bryan J
    Health Serv J; 1998 Apr; 108(5602):suppl 4-6. PubMed ID: 10180412
    [No Abstract]   [Full Text] [Related]  

  • 20. Executive summary of the GESIDA/National AIDS Plan Consensus Document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2015).
    ; Berenguer J; Polo R; Aldeguer JL; Lozano F; Aguirrebengoa K; Arribas JR; Blanco JR; Boix V; Casado JL; Clotet B; Crespo M; Domingo P; Estrada V; García F; Gatell JM; González-García J; Gutiérrez F; Iribarren JA; Knobel H; Llibre JM; Locutura J; López JC; Miró JM; Moreno S; Podzamczer D; Portilla J; Pulido F; Ribera E; Riera M; Rubio R; Santos J; Sanz-Moreno J; Sanz J; Téllez MJ; Tuset M; Rivero A
    Enferm Infecc Microbiol Clin; 2015 Oct; 33(8):544-56. PubMed ID: 26021186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.